Abstract-Effects of 12 compounds including 5-lipoxygenase (5-LO) inhibitors and antiallergic drugs on the activity of 5-LO from the polymorphonuclear leukocytes (PMN) of guinea pigs, rats, rabbits, monkeys and humans were examined. The 5-LO activity was inhibited by the drugs according to the following orders of efficacy: Guinea pig 5-LO, 5-HDHDMF>TZI-2721 >NDGA>AA861 >FPL55712>isopro terenol; rat 5-LO, 5-HDHDMF>AA861 >TZI-2721 >NDGA>FPL55712>KP-136 >MCI-826>benoxaprofen;
Slow reacting substance of anaphylaxis (SRS-A), which has been considered as one of important chemical mediators of allergic bronchial asthma, is now well-defined as a mixture of 3 metabolites, leukotriene (LT) C4, LTD4 and LTE4, generated from the precursor arachidonic acid through the 5-lipoxygenase (5-LO) pathway.
Purification and physicochemical prop erties of 5-LO have been extensively in vestigated by Samuelsson et al. (1) (2) (3) and other investigators (4) (5) (6) (7) (8) since the discovery of the enzyme in the leukocytes of the rabbit peritoneal cavity by Borgeat et al. (9) . On the other hand. it is hardly known whether polymorphonuclear leukocyte (PMN) derived 5-LO has any species difference in its sensitivity to drugs.
t Part of this work was presented at the 72nd Kinki Regional Meeting of the Japanese Pharmacologi cal Society, Nagoya, November 13, 1987 and at the 108th General Meeting of the Pharmaceutical Society of Japan, Hiroshima, April 4, 1988. In the present study, the effects of various drugs on the activities of 5-LO prepared from human, monkey, rabbit, rat and guinea pig PMN were compared.
Materials and Methods
Animals: Male Hartley guinea pigs weighing 550-650 g and male Wistar rats weighing 200-250 g were purchased from Shizuoka Laboratory Animal Center (Hamamatsu). Japanese white male rabbits weighing 3.0 3.5 kg (Shimizu Experimental Material Co. Ltd., Kyoto) and male rhesus monkeys weighing 7.5-9.0 kg (generously supplied by Central Research Laboratory, Nippon Shinyaku Co., Ltd., Kyoto) were also used in the experiment.
Reagents: Reagents used were casein, glutathione (GSH), adenosine-5'-triphos phate disodium salt trihydrate (ATP) and N (2 hydroxyethyl Preparation of guinea pig 5-LO: Guinea pig 5-LO was prepared according to the method of Ochi et al. (6). Two % casein-con taining saline was i.p. injected at a dose of 10 ml/100 g body weight. After 16 hr, the animal was sacrificed under ether anesthesia and 5 ml/animal of saline containing 300 U heparin was i.p. injected. The peritoneal fluid containing leukocytes was obtained after laparotomy. The peritoneal cavity was once rinsed with saline, 10 ml/animal, combined with the previous peritoneal fluid, and filtered on gauze. The filtrate was centrifuged at 1,000 x g for 5 min at 4 *C. The pellet was subjected to hypotonic shock with 0.2% saline (1 ml/animal) for 30 sec for hemolysis. After the same volume of 1.6% saline was added and centrifuged again under the above condition, the pellet was suspended with 50 mM HEPES buffer containing 0.5 mM EDTA (pH 8.0, EDTA/HEPES solution) at 2x108 PMN/ml. Then, the cell suspension was ultrasonicated at 20 kHz for 30 sec under ice cooling and centrifuged at 10,000xg for 10 min at 4°C. The supernatant was further cen trifuged at 105,000 x g for 60 min at 4'C. To 19.5 ml of the resultant supernatant were added 9 ml of 50% polyethylene glycol 6,000 and 1.5 ml of 2 M KCI. The mixture was allowed to stand for 30 min under ice-cooling and then centrifuged at 30,000xg for 10 min at 4°C. The precipitate was dissolved in 5 ml of EDTA/HEPES solution and recentrifuged at 30,000xg for 10 min at 4°C. Crude 5-LO of the supernatant was poured into a column (25 x 50 mm) of DEAE-Sephacel (Pharmacia), washed with EDTA/HEPES solution, and then eluted with EDTA/HEPES solution con taining 0.5 M KCI. The 5-LO fraction was con centrated using Mol Cut (M.W.=30,000, Nippon Millipore Ltd.) and used as the partially purified 5-LO enzyme reference of guinea pigs.
Preparation of rat and rabbit 5-LO: Similarly to guinea pigs, casein-treated rats were exsanguinated and 20 ml/animal of saline containing heparin (40 U/ml), 10 mM Na2HPO4 and 1 mM EDTA was i.p. injected. After collection of the peritoneal fluid con taining leukocytes, the peritoneal cavity was rinsed with saline (10 ml/animal). The washings were combined with the previously collected peritoneal fluid and then filtered through gauze. The filtrate was centrifuged at 1,000xg for 10 min at 4°C to obtain the PMN pellet.
Under pentobarbital anesthesia, 600 ml of 0.2% oyster glycogen/animal was i.p. in jected to rabbits, and the peritoneal fluid was collected 16-18 hr later. Following filtration of the fluid through gauze, the filtrate was centrifuged at 600 x g for 5 min at 4'C to obtain the PMN pellet.
Similarly to the guinea pig PMN pellet, hy potonic treatment and centrifugation were applied to the rat and rabbit PMN pellets. Either rat or rabbit PMN was suspended at 5 x 108 PMN and 2.5x`108 PMN/ml with EDTA/HEPES solution for rats and rabbits, respectively.
Both rat and rabbit PMN were ultrasonicat ed at 20 kHz for 30 and 10 sec, respectively, under ice-cooling.
The supernatants ob tained by centrifugation at 5,000xg for 10 min at 4°C were used as rat and rabbit 5-LO enzyme references, respectively.
Preparation of rhesus monkey and human 5-LO: A one-fifth volume of 6% dextran was added to heparinized peripheral blood samples (10 units heparin/ml blood) drawn from the rhesus monkey or a healthy human volunteer, and each mixture was subjected to upside down mixing. After allowing them to stand at room temperature, the upper layer containing leukocytes was aspirated.
The leukocyte layer of the rhesus monkey was centrifuged at 500 x g for 5 min at 4'C. The human leukocyte layer was layered on an equivolume of a 9% Ficoll-400/33.4% Conray-400 (24/10) solution and centrifuged at 500 x g for 30 min at 4'C. Both of the pellets were suspended at 5 x 107 PMN/ml with EDTA/HEPES solution following hy potonic treatment and centrifugation. Rhesus monkey and human PMN suspensions were ultrasonicated at 20 kHz for 40 and 10 sec, respectively, under ice-cooling. The super natants obtained by centrifugation at 5,000xg for 10 min at 4°C were used as the respective 5-LO references.
All procedures described above were carried out at 4°C, and all of the 5-LO references were kept at -80°C unitil use. Following vigorous stirring for 1 min, the reaction solution was centrifuged at 1,700 x g for 10 min at 4'C. One hundred al of the organic layer was spotted on a TLC plate. After saturation of the TLC plate with a developing solvent consisting of a mixture of diethylether/ petroleum ether/acetic acid (50/50/4) at room temperature, the TLC was developed under ice-cooling. After completion of the development, the portion corresponding to 14C-5-HETE reference , which was spotted on a site differing from the test sample site and developed simultaneously, was scraped out to measure its radioactivity. Triplicate measurements were carried out for each of the species-derived 5-LO ac tivities, and the effect of each drug was ex pressed by the mean formation rate (%) of 14C-5-HETE vs . the control or IC50 value obtained by the dose-reaction relationship.
Statistical analysis: IC50 values were tested statistically by the linear regression analysis of the concentration-reaction relation using the method of least squares.
Results
Effect on the guinea pig 5-LO activity: Table 1 and Fig. 2 show effects of the ex amined drugs on the guinea pig 5-LO activity. In the contro!, which was incubated after addition of 14C-AA to 5-LO in the absence of drugs, 14C-5-HETE of 9.1 x103 d.p.m. was formed. The treatment with AA861, 5 HDHDMF, TZI-2721 or NDGA inhibited 5 H ETE formation in a dose-dependent manner, and the IC50 values of the drugs were 0.47, 0.01, 0.045 and 0.27 ,uM, respectively.
At 100 ,uM, FPL55712 and isoproterenol produced almost complete inhibition and an approximately 50% inhibitory effect, respec tively; however, neither had an effect at 10 tiM. Other drugs had no effect, even at 100 ,a M. Effect on the rat 5-LO activity: The effects of drugs on the rat 5-LO activity are sum marized in Table 1 and Fig. 3 Other drugs had no effect at 100 PM. Effect on the rabbit 5-LO activity: Table 1 and Fig. 4 Effect on the rhesus monkey 5-LO activity: The effect of drugs on the rhesus monkey 5 LO activity are listed and depicted in Table 1 and Fig. 5 , respectively.
The control produced Other drugs had no inhibitory effect even at 100 SaM.
Effect on the human 5-LO activity: Table 1 and Fig. 6 show the effects of drugs on the human 5-LO activity. 14C-5-HETE of 5.0x103 d.p.m. was produced in the control. AA861, 5-HDHDMF, TZI-2721, NDGA and FPL 55712 inhibited the human 5-LO activity in a dose-dependent manner, and their IC50 values were 2.3, 0.22, 0.15, 0.35 and 32.6 ,aM, respectively. Other drugs did not inhibit the activity even at 100 It M. Discussion LTC4, LTD4 and LTE4 that are formed from arachidonic acid have been proven to induce a strong constriction of the airway smooth muscle, while LTE4 has been shown to have potent chemotactic activity on leukocytes. The considerable contribution of LTs to the Schultz-Dale reaction of isolated human bronchial muscle in vitro has been also sug gested (10). Furthermore, it has been re ported that the PM N derived from patients with allergic bronchial asthma produced more 5-HETE than those from healthy subjects (11). These data strongly suggest that LTs play important roles in provoking allergic bronchial asthma.
Meanwhile, it has been described that the mouse auricle inflammations elicited by calcium ionophore A23187 (12), arachidonic acid (13) In this paper, the effects of 5-LO inhibitors (AA861, 5-HDHDMF, TZI-2721), LT antagonists (FPL55712, MCI-826), antial lergic agents (tranilast, KP-136 which is under development and its active metabolite C4C), bronchodilators (isoproterenol, the ophylline) and dual inhibitors of arachidonic acid metabolism (NDGA, benoxaprofen) on the 5-LO activities derived from guinea pig, rat, rabbit, monkey and human PMN were evaluated.
All 5-LO inhibitors could inhibit the 5-LO activity derived from all animal species in a dose-dependent manner, but the inhibitory effects were considerably different among the different animal species and drugs: AA861 had the most potent inhibitory effect on rat 5-LO, but the inhibitory effects on the guinea pig, rabbit and human 5-LO activities were approximately 1/4, 1/10 and 1/20 of that on rat 5-LO activity, respectively. The IC50 value (0.47 W) of AA861 on the guinea pig 5-LO activity was nearly equal to that re ported by Yoshimoto et al. (21) The inhibitory effects of 5-HDHDMF on the guinea pig and rat 5-LO activities were very similar, but the effect on the human 5 LO activity was much weaker (approximately 1/20).
The inhibitory effect of TZI-2721 on the guinea pig 5-LO activity was approximately 70 times stronger than that on the rhesus monkey 5-LO activity.
On the other hand, N DGA had a concen tration-dependent and nearly equal effect to inhibit the guinea pig, rat, rabbit and human 5-LO activities. Although benoxaprofen showed a weak inhibitory effect on only the rat 5-LO activity, it had no effect on the 5-LO activities derived from other animal species.
MCI-826 and KP-136 did not inhibit the human, monkey and guinea pig 5-LO ac tivities even at concentrations as high as 100 ,aM. However, MCI-826 and KP-1 36 exerted concentration-dependent inhibitory effects on the rat 5-LO activity and both rat and rabbit 5-LO activities, respectively.
These results strongly suggest that there are significant differences in the sensitivities of 5-LO derived from guinea pig, rat, rabbit, monkey and human PMN to various drugs.
Ishizaka et al. (29) . Therefore, isoproterenol is considered to rarely participate in direct LT formation by the immunological reaction.
Walker and Dawson (22) reported that benoxaprofen inhibited the rabbit neutrophil derived 5-LO activity. Harvey and Osborne (19) also demonstrated that the activity of 5-LO derived from guinea pig PMN was inhi bited by the drug. On the contrary, McMillan et al. (17) proved that the human 5-LO ac tivity was not inhibited by the drug. These results strongly support our experimental data indicative of a species difference in the sensitivity of 5-LO to drugs.
